Tube of PAR-2 Agonist 2 amide peptide
Peptides

Protease-Activated Receptor-2, PAR-2 Agonist 2, amide - 5 mg

$340.00
Check your price
  • Cat.Number : AS-60217-5
  • Availability :
    In stock

Quantity

Add to wishlist

This protease-activated receptor activating peptide (PAR-2-AP) corresponds to the PAR-2 tethered ligand.

Specifications

Chemistry
Sequence one letter code
  • SLIGKV-NH2
Sequence three letter code
  • H-Ser-Leu-Ile-Gly-Lys-Val-NH2
CAS registry number
  • 190383-13-2
Molecular Formula
  • C28H54N8O7
Molecular Mass/ Weight
  • 614.8
Modification
Conjugation
  • Unconjugated
Quantity & Purity
Purity
Storage & stability
Form
  • Lyophilized
Storage Conditions
  • - 20 °C
Activity
Biomarker Target
Research Area
Sub-category Research Area
Usage
  • Research use
Source
Source / Species
  • human
Codes
Code Nacres
  • NA.26

Downloads

You may also be interested in the following product(s)

Image of a kit SensoLyte 520 Factor Xa Assay Kit Fluorimetric

SensoLyte® 520 Factor Xa Assay Kit Fluorimetric - 1 kit

Cat.Number : AS-72208
$631.00 Excl. Tax
Image of a kit SensoLyte 520 Thrombin Activity Assay Kit Fluorimetric

SensoLyte® 520 Thrombin Activity Assay Kit Fluorimetric - 1 kit

Cat.Number : AS-72129
$669.00 Excl. Tax
Image of a kit SensoLyte AFC Plasmin Activity Assay Kit Fluorimetric

SensoLyte® AFC Plasmin Activity Assay Kit Fluorimetric - 1 kit

Cat.Number : AS-72124
$461.00 Excl. Tax

Citations

Thrombin- and Factor Xa–induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells.

Circ. Res . 2003 Dec 11 ; 94(3) 340 | DOI : 10.1161/01.RES.0000111805.09592.D8

  • BH. Rauch
  • et al

Thrombin and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells

Circ Res. . 2003 Dec 11 ; 94(3) 340 | DOI : 10.1161/01.RES.0000111805.09592.D8

  • BH. Rauch
  • et al

Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.

Mol Cancer Res. . 2008 Jun 01 ; 6(6) 1D46 | DOI : 10.1158/1541-7786.MCR-08-0096

  • G. Mize
  • et al